Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease
Population
Patients with coronary artery disease, including specific subgroups such as elderly, frail, diabetic, renal…
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
Informs individualized long-term DAPT decisions in CAD; extends prior consensus with scenario-specific guidance for clinicians and trials.
Structured PICO
P
Population
Patients with coronary artery disease, including specific subgroups such as elderly, frail, diabetic, renal dysfunction, peripheral obliterative arteriopathy, recurrent ischaemic events, those receiving oral anticoagulation, and those at high bleeding risk
I
Intervention
Long-term antiplatelet therapy / Dual antiplatelet therapy (DAPT)
This consensus document provides comprehensive recommendations on the use and duration of long-term dual antiplatelet therapy across various clinical scenarios and high-risk patient subgroups with coronary artery disease.
Cite This Study
Gulizia et al. (2018) studied this question.